相关实验视频
Updated: Jul 9, 2025
09:29
Skeletal Muscle Gender Dimorphism from Proteomics
Published on: December 14, 2011
12.6K
心脏衰竭的循环生物标志物中的性别差异
Roopa A Rao1, Anju Bhardwaj2, Mrudula Munagala3
1Division of Cardiovascular Medicine, Indiana University School of Medicine, 1801, N Senate Blvd, Indianapolis, IN, 46202, USA. rrao@iuhealth.org.
Current heart failure reports
|December 7, 2023
概括
心力衰竭生物标志物的性别差异是显而易见的,但它们的临床影响仍然不清楚. 需要进一步的研究来了解这些变异,以便在男性和女性中更好地诊断和治疗.
科学领域:
- 心脏病学 心脏病学
- 生物标志物研究 生物标志物研究
- 医学中的性别差异.
背景情况:
- 越来越多的证据突出了基于性别的心力衰竭差异.
- 对心脏生物标志物的性别特异性值的临床意义尚不清楚.
- 了解这些差异对于心血管疾病的个性化医学至关重要.
研究的目的:
- 审查目前对心力衰竭中的心脏生物标志物性别差异的理解.
- 探索这些性别特异性生物标志物值的临床相关性.
- 在性别特异性心力衰竭生物标志物研究中识别知识差距和新兴研究领域.
主要方法:
- 关于心力衰竭生物标志物中性别差异的最新科学文献的综述.
- 对调查男性和女性不同生物标志物值的研究进行分析.
- 探索新的生物标志物和技术,包括蛋白质组学和微RNA.
主要成果:
- 雌性对某些生物标志物表现出不同的值,例如较低的热素和较高的NT-proBNP水平.
- 在性别特定的背景下,ST-2,Galectin 3和其他生物标志物的临床相关性仍然模两可.
- 尽管在生物标志物表达中观察到与性别相关的差异,但用于诊断和预后的临床实践的转化是有限的.
结论:
- 心力衰竭生物标志物的性别特异存在,但需要进一步研究临床应用.
- 新型生物标志物和先进技术,如机器学习正在探索,以弥合知识差距.
- 考虑基于性别的变异的个性化方法对于改善心力衰竭管理至关重要.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
96
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
96
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
167
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
167
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: β-Blockers
342
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
342
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436